Admin
行政
基本信息
- 批准号:10225392
- 负责人:
- 金额:$ 4.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-09 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdvocateAnimal Cancer ModelAnnual ReportsAreaBiochemistryBiophysicsBreastBreast Cancer PatientBreast Cancer TreatmentBreast OncologyBudgetsCaliforniaCancer CenterCharitiesClinical MedicineClinical TrialsClipCollaborationsCommunicationCommunication ProgramsDNADataDeaminaseDevelopmentDiagnosisEducational workshopElectronic MailElementsEndocrineEnsureEventFamilyFeedbackFoundationsGeographyGoalsGrantGrowth FactorHIVHuman ResourcesInstitutesInstitutionInvestigationInvestigational TherapiesLaboratoriesLeadershipLogisticsMammary NeoplasmsMedialMedicalMinnesotaMolecular BiologyMutagenesisNeoadjuvant TherapyOnline SystemsPatientsPersonsPharmaceutical PreparationsPhysiciansPostdoctoral FellowProductionProgram DevelopmentPublicationsReagentReportingResearchResearch PersonnelResource SharingRoleScienceScientistSeedsServicesSignal PathwaySiteSomatotropinSystemTechnologyTelephoneTravelUniversitiesUpdateVideoconferencingVirusVotingWorkXenograft Modelbaseexperiencefallsfrontiergraduate studenthormonal signalsinnate immune mechanismsmalignant breast neoplasmmaterial transfer agreementmeetingsmembermultidisciplinaryoperationorganizational structureoutreachpaymentpre-clinicalprofessorprogramsrepositorysocialstemsuccesssymposiumtraining opportunityweb site
项目摘要
CORE A – ADMINISTRATION
ABSTRACT
The primary goals of Core A – Administration are to provide leadership, logistical support, and coordinated
communication for all Program members and collaborators in order to expedite the successful completion of
the Program's scientific aims. The PI of Core A is Douglas Yee and the Co-I is Reuben Harris. The specific
aims of the Core are to 1) provide strong and consistent leadership; 2) provide services to Program scientists,
collaborators, and External Advisory Board members; and 3) coordinate Program communications including
meetings, workshops, and outreach efforts. The efficient administration of this bi-institutional, multi-investigator
Program is essential to its success and has proved to be effective over the 7 years that this team has been
working together.
Yee and Harris both have experience managing multi-investigator, matrixed grants, and they meet monthly
to coordinate Program management. They are supported by a Program Manager, Jane Balster, who provides
day-to-day administrative support and coordinates meetings, workshops, and other communication and
outreach activities. The Executive Leadership Team, which consists of Project and Core PIs, meets monthly to
review the status of scientific progress and budgets. In-person Program Workshops, which include Project and
Core PIs, Co-Is, postdocs, graduate students, and other personnel, will continue to be held twice each year,
alternating between the University of Minnesota (fall) and University of California San Diego (spring). The
External Advisory Board, which consists of 5 expert scientists and 3 patient advocates, regularly participates in
weekly meetings and meets twice each year in conjunction with the bi-annual in-person Program Workshop.
Additional meetings of PIs, Project personnel, Core personnel, outside collaborators, and all Program-
associated personnel occur on a weekly or monthly basis. Web-based conferencing facilitates the participation
of team members who are geographically dispersed.
核心 A – 管理
抽象的
核心 A – 管理的主要目标是提供领导、后勤支持和协调
与所有计划成员和合作者进行沟通,以加快成功完成
该计划的科学目标是 Core A 的 PI 是 Douglas Yee,Co-I 是 Reuben Harris。
核心的目标是 1) 提供强有力和一致的领导;2) 为计划科学家提供服务,
合作者和外部顾问委员会成员;以及 3) 协调计划沟通,包括
会议、研讨会和外展工作的有效管理。
该计划对于其成功至关重要,并且在该团队执行的 7 年中已被证明是有效的
一起工作。
Yee 和 Harris 都有管理多位研究者、矩阵式资助的经验,他们每月会面一次
他们由项目经理 Jane Balster 提供支持,她负责提供服务。
日常行政支持并协调会议、研讨会和其他沟通和
执行领导团队由项目和核心 PI 组成,每月举行一次会议
审查科学进展和预算的状况,包括项目和预算。
核心PI、Co-Is、博士后、研究生和其他人员,将继续每年举行两次,
明尼苏达大学(秋季)和加州大学圣地亚哥分校(春季)交替。
外部顾问委员会由 5 名专家科学家和 3 名患者倡导者组成,定期参与
每周举行一次会议,每年举行两次会议,并与每两年一次的现场计划研讨会一起举行。
PI、项目人员、核心人员、外部合作者和所有计划人员的额外会议
相关人员每周或每月举行一次基于网络的会议,以促进参与。
地理上分散的团队成员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Douglas Yee其他文献
Douglas Yee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Douglas Yee', 18)}}的其他基金
Disrupting insulin receptor function in breast cancer
破坏乳腺癌中的胰岛素受体功能
- 批准号:
10171816 - 财政年份:2020
- 资助金额:
$ 4.52万 - 项目类别:
Disrupting insulin receptor function in breast cancer
破坏乳腺癌中的胰岛素受体功能
- 批准号:
10625994 - 财政年份:2020
- 资助金额:
$ 4.52万 - 项目类别:
Disrupting insulin receptor function in breast cancer
破坏乳腺癌中的胰岛素受体功能
- 批准号:
10028995 - 财政年份:2020
- 资助金额:
$ 4.52万 - 项目类别:
Disrupting insulin receptor function in breast cancer
破坏乳腺癌中的胰岛素受体功能
- 批准号:
10412979 - 财政年份:2020
- 资助金额:
$ 4.52万 - 项目类别:
相似国自然基金
REGγ动物肿瘤模型的建立与研究
- 批准号:81071657
- 批准年份:2010
- 资助金额:40.0 万元
- 项目类别:面上项目